If you experience PsA symptoms, even with your current treatment, consider a clinical trial that may help reduce symptoms.
You may qualify for a clinical trial.
As you may know, PsA is an autoimmune disease and affects some people who have psoriasis, which is a skin disease that presents as red, scaly rashes most often on the elbows, knees, ankles, feet, and hands. PsA causes the immune system to attack the joints, leading to inflammation. This results in pain, stiffness, and swelling in the joints. Symptoms of PsA can vary from person to person and change locations in the body. It can also affect any joint in the body and could affect just one joint or multiple joints at a time.
Managing PsA is important because without treatment, the condition can lead to joint damage. However, just as the symptoms can vary from person to person, the treatment can also vary. For some patients with PsA, their current treatment is inadequate. Whether you are just starting your journey with PsA or trying to find a different treatment option, you may be considering your next steps. Your participation in clinical trials that focus on PsA may help pave the way to develop more potential treatments for future patients with PsA.
Below you will find a list of clinical trials that are sponsored by Bristol Myers Squibb (BMS). Click the "View Trial Details" links to get more information about each trial. From the top of any trial page, click the purple “Pre-Screen Now” button to answer a few questions and find out if one of the clinical trials might be right for you.
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor TreatmentView Trial Details
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic DrugsView Trial Details
Does PsA affect only the joints?
PsA affects the joints, but it can also include other symptoms, such as a red, scaly rash most often on the elbows, knees, ankles, feet, or hands; tiredness; swelling of the fingers or toes; and eye inflammation. (4)More FAQs
Are only women and older adults affected by PsA?
Men and women are at equal risk for PsA. Age is not a factor in developing PsA – most people are diagnosed between 30 and 55 years of age, but PsA can be diagnosed during childhood. (5)More FAQs
If you decide you are ready to be a part of a clinical trial but are unsure where to start, completing the pre-screener questionnaire is the first step. This questionnaire includes questions about your diagnosis that will help find clinical trials that you may match to.
You may be nervous at first, but taking action by completing this questionnaire could potentially help others by contributing to PsA research. If you do decide to enter a clinical trial, you are free to change your mind about participating at any point during the trial.
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
Have questions? Live support is available 24/7 - Call 855-907-3286 or email firstname.lastname@example.org